Cargando…
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
The emergence of the coronavirus 2019 (COVID-19) pandemic has presented an unprecedented global challenge. Vaccines against COVID have been developed to date. Covid-19 has been linked with the development of Guillain-Barre Syndrome (GBS), a rare immune-mediated demyelinating neuropathy. We report th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447540/ https://www.ncbi.nlm.nih.gov/pubmed/34560365 http://dx.doi.org/10.1016/j.jneuroim.2021.577719 |